CLINICAL AND DIAGNOSTIC SIGNIFICANCE OF DEFENSINS IN THE DEVELOPMENT OF DENTAL CARIES AND CHRONIC CATARRHAL GINGIVITIS IN CHILDREN WITH SPECIAL NEEDS
DOI:
https://doi.org/10.32782/2786-7684/2026-2-8Keywords:
children with special needs, dental caries, chronic catarrhal gingivitis, defensins, oral fluidAbstract
Introduction. Determination of defensin concentration in oral fluid is a promising diagnostic criterion for assessing the risk of dental caries and periodontal inflammatory diseases, as well as a potential marker of the effectiveness of preventive and therapeutic interventions. The aim of the study was to evaluate the diagnostic potential of defensins in dental caries and chronic catarrhal gingivitis in children with special needs over time. Materials and methods. Sixty-six children aged 7 to 18 years were examined and divided into two groups: the main group (n = 31) consisted of children with special needs who had clinical signs of hard dental tissue lesions and inflammatory periodontal diseases, and the comparison group (n = 35) included age-matched children without systemic developmental disorders and with a healthy oral cavity. Children in the main group underwent professional oral hygiene and dental treatment; the oral mucosa was treated with a sorbent solution (Enterosgel) and an anti-inflammatory agent (Stomatofyt A-spray), while a calcium-containing gel was applied to hard dental tissues along with oral administration of calcium citrate. Defensin levels in oral fluid were determined using an enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using MS Excel and the licensed statistical software Biostat. Results. It was found that children with special needs had significantly lower levels of α-defensins in oral fluid prior to treatment compared with the comparison group. After the implementation of therapeutic and preventive measures, a significant increase in α-defensin concentrations in oral fluid was observed in the main group at 6 and 12 months of follow-up (p < 0.05). The most pronounced positive dynamics of α-defensin levels were observed in older children (13–18 years) and in children with mild to moderate cognitive impairment, which may be associated with better adaptation of local immune defense mechanisms and more effective oral hygiene practices. Conclusions. Correlation analysis revealed statistically significant positive relationships between age and post-treatment α-defensin levels (r = 0.54–0.74; p < 0.05), as well as a negative correlation between the severity of cognitive impairment and α-defensin concentration in oral fluid (r = −0.71; p < 0.05).
References
Godovanets O, Kitsak T, Kuzniak B. Clinical characteristics of chronic catarrhal gingivitis in children aged 12-15 years. Ukr. Dent. Alm. [Internet]. 2025Oct.8 [cited 2026May13];(3):72-7. Available from: https://dental-almanac.org/index.php/journal/article/view/748 in Ukrainian
Smolyar N.I., Chukhray N.L. Features of Dental Status and Local Immunity in Children with Special Needs. News of Dentistry. 2022;1:34–39. in Ukrainian
Nazarenko IV, Hodovanets OI. Role of Antimicrobial Peptides in the Development of Dental Diseases in Children. Bukovinian Medical Herald. 2021;25(3):112–118. in Ukrainian
Kaskova L.F., Amosova L.I., Ulasevych L.P. Oral Microbiocenosis and Local Immunity Factors in Children with Dental Caries. Visnyk Stomatolohii (Bulletin of Dentistry). 2020;4:72–77. in Ukrainian
Bidenko N.V., Kazakova R.V., Rozhko M.M. The State of Local Oral Immunity in Children with Dental Pathology. Ukrainian Dental Almanac. 2019;2:45–49. in Ukrainian
World Health Organization. Global Oral Health Status Report: Towards Universal Health Coverage for Oral Health by 2030. Geneva: WHO; 2022. https://iris.who.int/handle/10665/364538
Gorr SU. Antimicrobial peptides in periodontal innate defense. Front Oral Health. 2021;2:639686. DOI:10.3389/froh.2021.639686
Pärnänen P, Meurman JH, Sorsa T. The role of salivary antimicrobial peptides in oral health and disease. J Oral Microbiol. 2020;12(1):1763452. DOI: 10.1080/20002297.2020.1763452
Pérez-Sayáns M, Suárez-Peñaranda JM, Gándara Vila P, et al.“Salivary biomarkers in oral diseases.”Journal of Clinical and Experimental Dentistry. 2020;12(10):e1010–e1018 DOI: 10.4317/jced.57086
Tokajuk G, Niemczuk M, Deptuła P, et al. Cathelicidin and defensins in oral cavity and their role in oral diseases. Postepy Hig Med Dosw. 2020;74:223–234. DOI: 10.5604/01.3001.0014.5497
Seyedmajidi M, Khani S, Haghanifar S, et al. Evaluation of salivary alpha defensin levels in children with severe early childhood caries. Eur Arch Paediatr Dent. 2019;20(6):567–573. DOI: 10.1007/s40368-019-00443-6
Zhang L, Yu W, He T, et al. Contribution of the antimicrobial peptide LL-37 in defense and disease of the oral cavity. Oral Dis. 2019;25(3):575–585. DOI: 10.1111/odi.12943
Sahingur SE, Yeudall WA. Chemokine function in periodontal disease and oral cavity cancer. Front Immunol. 2019;10:1211. DOI: 10.3389/fimmu.2019.01211
Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2019;32(5):241–248.
Wang GP. Defensins and human innate immunity. Front Biosci. 2019;4:545–558.
Vieira AR, Modesto A, Marazita ML. Caries: review of human genetics research. Caries Res. 2018;52(3):491–506. DOI: 10.1159/000484594
Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2018;69(1):7–17. DOI: 10.1111/prd.12104
Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol. 2018;16(1):1–13. DOI: 10.1038/nrmicro.2017.120
Prasad M, Lambe UP, Brar B, et al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed Pharmacother. 2018;97:1521–1537. DOI: 10.1016/j.biopha.2017.10.147
Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol. 2018;29:31–48.
Squier CA, Brogden KA. Human Oral Mucosa: Development, Structure and Function. Wiley Blackwell; 2017. DOI: 10.1002/9781118951035
Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol. 2017;55(3):764–773. DOI: 10.1128/JCM.01946-16
Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2017;13(4):547–558.
Singh PK, Jia HP, Wiles K, et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA. 2016;95(25):14961–14966. DOI: 10.1073/pnas.95.25.14961
Hancock REW, Haney EF, Gill EE. The immunology of host defense peptides: beyond antimicrobial activity. Nat Rev Immunol. 2016;16(5):321–334. DOI: 10.1038/nri.2015.7
Gardner MS, Rowland MD, Siu A, et al. A comprehensive defensin assay for saliva. Analytical Chemistry. 2009;81(2):557–566. DOI: 10.1021/ac8019776
Sheskin DJ. Handbook of Parametric and Nonparametric Statistical Procedures. 5th ed. Boca Raton: CRC Press; 2020. DOI: 10.4324/9780203489536






